(Q36900726)

English

Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer

scientific article published on July 2007

Statements

Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer (English)
Douglas C Hanson
Dennis A Noe
Robert Millham
Deborah J Guyot
Steven H Bernstein
Paul C Canniff
Amarnath Sharma
Jesus Gomez-Navarro
873-883

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit